Kett; Nathan R.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kett; Nathan R..The latest application filed is for "inhibitors of catechol o-methyl transferase and their use in the treatment of psychotic disorders".

Company Profile

0.10.11

Kett; Nathan R. - Franklin TN
Kett; Nathan R. - Perkiomenville PA
Kett; Nathan R. - Perkiornenville NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Inhibitors of catechol O-methyl transferase and their use in the treatment of psychotic disorders Grant 9,399,651 - Wolkenberg , et al. July 26, 2	2016-07-26
Inhibitors of catechol O-methyl transferase and their use in the treatment of psychotic disorders Grant 9,260,413 - Wolkenberg , et al. February 16, 2	2016-02-16
Inhibitors Of Catechol O-methyl Transferase And Their Use In The Treatment Of Psychotic Disorders App 20150299227 - Wolkenberg; Scott ; et al.	2015-10-22
Inhibitors of catechol O-methyl transferase and their use in the treatment of psychotic disorders Grant 8,969,364 - Wolkenberg , et al. March 3, 2	2015-03-03
Inhibitors Of Catechol O-methyl Transferase And Their Use In The Treatment Of Psychotic Disorders App 20150024071 - Wolkenberg; Scott ; et al.	2015-01-22
Inhibitors Of Catechol O-methyl Transferase And Their Use In The Treatment Of Psychotic Disorders App 20130196002 - Wolkenberg; Scott ; et al.	2013-08-01
Quinolone neuropeptide S receptor antagonists Grant 8,389,720 - Barrow , et al. March 5, 2	2013-03-05
Potassium channel inhibitors Grant 8,148,535 - Trotter , et al. April 3, 2	2012-04-03
Pyridine derivative potassium channel inhibitors Grant 8,080,543 - Trotter , et al. December 20, 2	2011-12-20
Quinolone Neuropeptide S Receptor Antagonists App 20110212946 - Barrow; James C. ; et al.	2011-09-01
Isoquinoline potassium channel inhibitors Grant 7,763,614 - Isaacs , et al. July 27, 2	2010-07-27
Decahydroquinoline Analogs As Cb2 Receptor Modulators, Useful In The Treatment Of Pain, Respiratory And Non-respiratory Diseases App 20100099673 - Bilodeau; Mark T. ; et al.	2010-04-22
Isoquinoline potassium channel inhibitors Grant 7,691,879 - Trotter , et al. April 6, 2	2010-04-06
Imidazopyridine Analogs As Cb2 Receptor Modulators, Useful In The Treatment Of Pain, Respiratory And Non-respiratory Diseases App 20090325936 - Bilodeau; Mark T. ; et al.	2009-12-31
Potassium Channel Inhibitors App 20090233897 - Trotter; B. Wesley ; et al.	2009-09-17
Potassium Channel Inhibitors App 20090069283 - Trotter; B. Wesley ; et al.	2009-03-12
Isoquinoline potassium channel inhibitors App 20070054892 - Isaacs; Richard ; et al.	2007-03-08
Isoquinoline potassium channel inhibitors App 20060276450 - Trotter; B. Wesley ; et al.	2006-12-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.